Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE)
Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) is a monoclonal antibody targeting GPC3 (glypican-3). It induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth and can be used in the research of hepatocellular carcinoma (HCC). MW :145.58 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3151 |
| Sku # | A3151-1mg*5 |
| Pricing | 1mg*5, $970.00 |